pethidine / Samaritan Pharma 
Welcome,         Profile    Billing    Logout  
 0 Diseases   21 Trials   21 Trials   322 News 
1 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pethidine / Samaritan Pharma
2016-004501-14: COOL-AMI EU PIVOTAL TRIAL: A MULTICENTER, PROSPECTIVE, RANDOMIZED- CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFECTIVENESS OF COOLING AS AN ADJUNCTIVE THERAPY TO PERCUTANEOUS INTERVENTION INP A TIENTS WITH ACUTE MYOCARDIAL INFARCTION COOL-AMI EU PIVOTAL-STUDIE: EINE MULTIZENTRISCHE, PROSPEKTIVE, RANDOMISIERTE, KONTROLLIERTE STUDIE ZUR BEURTEILUNG DER SICHERHEIT UND WIRKSAMKEIT VON KÜHLUNG ALS BEGLEITTHERAPIE ZUR PERKUTANEN INTERVENTION BEI PATIENTEN MIT AKUTEM MYOKARDINFARKT

Not yet recruiting
3
468
Europe
Buspirone Hydrochloride, Pethidin-hameln 50 mg/ml, Pethidine Hydrochloride, Tablet, Solution for injection, Anxut 5 mg, Pethidin-hameln 50 mg/ml, Anxut 10 mg
ZOLL, Inc., ZOLL, Inc.
Acute Myocardial Infarction Akuter Myokardinfarkt, Myocardial infarction Herzinfarkt, Diseases [C] - Cardiovascular Diseases [C14]
 
 

Download Options